Rytų klinika - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 192,951 | 157,753 | 118,326 | 381,005 | 523,730 | 582,259 | 525,125 | 454,835 |
| Profit before tax | 90,752 | 55,980 | 31,022 | 83,077 | 74,674 | 93,793 | 20,238 | -46,330 |
| Net profit | 86,214 | 53,181 | 29,471 | 70,615 | 63,572 | 80,341 | 16,937 | -46,330 |
| Equity | 137,246 | 160,428 | 167,698 | 234,313 | 297,885 | 378,225 | 395,163 | 348,731 |
| Liabilities | - | - | - | - | 158,166 | 216,191 | 137,685 | 203,809 |
| Non-current assets | 111 | 1 | 1 | 201,828 | 304,919 | 344,753 | 305,608 | 217,622 |
| Current assets | 145,479 | 165,532 | 174,434 | 169,388 | 151,132 | 249,663 | 226,078 | 334,918 |
| Total assets | 145,590 | 165,533 | 174,435 | 371,216 | 456,051 | 594,416 | 531,686 | 552,540 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 25,223 | 33,898 | 27,792 |
| Social insurance contributions | - | - | - | - | - | 22,356 | 23,760 | 24,403 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +3.8% | -18.2% | -25.0% | +222.0% | +37.5% | +11.2% | -9.8% | -13.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 59.2% | 32.1% | 16.9% | 19.0% | 13.9% | 13.5% | 3.2% | -8.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 62.8% | 33.1% | 17.6% | 30.1% | 21.3% | 21.2% | 4.3% | -13.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 44.7% | 33.7% | 24.9% | 18.5% | 12.1% | 13.8% | 3.2% | -10.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 47.0% | 35.5% | 26.2% | 21.8% | 14.3% | 16.1% | 3.9% | -10.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 0.5 | 0.6 | 0.3 | 0.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 26,016 | 19,516 | 14,489 | 47,626 | 45,542 | 49,554 | 41,186 | 34,113 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Rytų klinika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-11-18 | 2025-11-23 | 1747.71 |
| 2021-12-16 | 2021-12-22 | 1255.91 |
| 2021-10-18 | 2021-10-24 | 598.28 |
Rytų klinika - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-13 | 2026-03-13 | 1331.0 |
| 2026-01-17 | 2026-01-19 | 856.42 |
| 2025-07-02 | 2025-07-20 | 63.77 |
| 2025-07-01 | 2025-07-01 | 1915.29 |
| 2025-06-30 | 2025-06-30 | 1902.6 |
| 2025-06-25 | 2025-06-29 | 1851.63 |
| 2025-06-19 | 2025-06-24 | 2648.63 |
| 2025-06-18 | 2025-06-18 | 2210.5 |
| 2025-06-17 | 2025-06-17 | 1770.5 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Rytu klinika, MB (code 132289090) is a Lithuanian small partnership engaged in medical specialists activities. In 2025, the latest financial year, revenue declined to €454.8K from €525.1K in 2024 and €582.3K in 2023, reflecting a two-year decrease of 21.9% and a year-on-year drop of 13.4%. Profitability weakened materially over the period. Net profit fell from €80.3K in 2023 to €16.9K in 2024, before turning into a €46.3K loss in 2025, with the profit margin at -10.2%. The balance sheet remained moderately leveraged, with equity of €348.7K, liabilities of €203.8K and total assets of €552.5K at the end of 2025. The equity ratio stood at 63.1%, while debt-to-equity was 0.58. Asset turnover was 0.82x. Revenue per employee was €35.0K, and profit per employee was -€3.6K. Overall, the company kept a solid equity base, but 2025 was marked by lower revenue, weaker efficiency and a negative bottom line.